Advances in targeted alpha therapy of cancer

Sathekge, Mike Machaba; Morgenstern, Alfred

dc.contributor.author	Sathekge, Mike Machaba
dc.contributor.author	Morgenstern, Alfred
dc.date.accessioned	2024-10-22T08:49:05Z
dc.date.issued	2024-04
dc.description.abstract	No abstract available.	en_US
dc.description.department	Nuclear Medicine	en_US
dc.description.embargo	2025-02-20
dc.description.librarian	hj2024	en_US
dc.description.sdg	SDG-03:Good heatlh and well-being	en_US
dc.description.uri	http://link.springer.com/journal/259	en_US
dc.identifier.citation	Sathekge, M., Morgenstern, A. Advances in targeted alpha therapy of cancer. European Journal of Nuclear Medicine and Molecular Imaging 51, 1205–1206 (2024). https://doi.org/10.1007/s00259-024-06658-1.	en_US
dc.identifier.issn	1619-7070 (print)
dc.identifier.issn	1619-7089 (online)
dc.identifier.other	10.1007/s00259-024-06658-1
dc.identifier.uri	http://hdl.handle.net/2263/98701
dc.language.iso	en	en_US
dc.publisher	Springer	en_US
dc.rights	© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. The original publication is available at : http://link.springer.comjournal/259.	en_US
dc.subject	Targeted alpha therapy	en_US
dc.subject	Cancer	en_US
dc.subject	SDG-03: Good health and well-being	en_US
dc.subject	Editorial	en_US
dc.title	Advances in targeted alpha therapy of cancer	en_US
dc.type	Postprint Article	en_US